China Medical GatewayLoading your healthcare gateway…

Jia Ning

Jia Ning — Associate Chief Physician — Medical Oncology — Peking Union Medical College Hospital

Specialties

Clinical medicine mainly engages in the comprehensive application of internal medicine therapies such as chemotherapy, molecular targeted therapy, and immunotherapy for malignant tumors including head and neck cancer, lung cancer, gastrointestinal tumors, breast cancer, and soft tissue sarcomas (including gastrointestinal stromal tumors, GIST). The research direction of basic medicine is tumor molecular biomarkers and precision medicine.

Education

Doctor of Oncology, visiting scholar at the University of Washington, USA. In 2009, completed clinical research theory and practice training at the National Institutes of Health (NIH) in the United States. In 2011, went to the Fred Hutchinson Cancer Research Center / University of Washington / Seattle Cancer Care Alliance in the United States for in-depth research on the treatment of breast cancer, esophagogastric cancer, colorectal cancer, and soft tissue sarcoma.

Professional Experience

Associate Chief Physician and Associate Professor in the Department of Oncology at Peking Union Medical College Hospital. He was selected for the first batch of the 'Hundred Talents Program' for young and middle-aged talents at Peking Union Medical College Hospital. He currently serves as a core expert in the Head and Neck Tumor and Lateral Skull Base Tumor Difficult Case Consultation Center at Peking Union Medical College Hospital, and as a principal investigator (PI) of clinical trials at the hospital, he leads multiple global and domestic new drug clinical trial studies.

Professional Roles

Served as a registered doctor for the Gleevec Assistance Program for gastrointestinal stromal tumors (GIST) (China Charity Federation), an executing doctor for the Sutent Assistance Program for kidney cancer and GIST (China Cancer Foundation), a registered doctor for the Opdivo Patient Assistance Program (China Cancer Foundation), and a registered doctor for the Tumor Immunotherapy Patient Assistance Program (China Primary Health Care Foundation).

Return to Home